The MarketWatch News Department was not involved in the creation of this content. -- NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in ...
NMD Pharma will also present an update on the ongoing SYNAPSE-MG Phase 2b clinical trial of ignaseclant in generalized myasthenia gravisAarhus, ...
Building muscle through strength training increases your basal metabolic rate (BMR), meaning you'll burn more calories even at rest.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果